Dr. Jean Marie Stassen - Amakem
Dr. Jean Marie Stassen has been appointed as Vice President, Research and Development at Amakem.
Stassen comes from Boehringer Ingelheim where he served as a Research Project Leader for the cardiovascular therapeutic area, and is co-founder of FlandersBio.
“I am delighted to welcome Jean Marie to Amakem where his vast experience in product and corporate development in the ophthalmology space will prove to be a tremendous asset to the Company as we continue to progress our lead product AMA0076 for the treatment of glaucoma,” said CEO Dr. Jack Elands.
